TFGT
CLDX icon

TS Financial Group (TSFG)’s Celldex Therapeutics CLDX Stock Holding History

TS Financial Group (TSFG)’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2K Hold
50
– – ﹤0.01% 764
2026
Q1 		$2K Hold
50
– – ﹤0.01% 731
2025
Q4 		$1K Hold
50
– – ﹤0.01% 765
2025
Q3 		$1K Hold
50
– – ﹤0.01% 778
2025
Q2 		$1K Hold
50
– – ﹤0.01% 752
2025
Q1 		$1K Hold
50
– – ﹤0.01% 747
2024
Q4 		$1K Hold
50
– – ﹤0.01% 692
2024
Q3 		$2K Sell
50
-50
-50% -$1.91K ﹤0.01% 677
2024
Q2 		$4K Hold
100
– – ﹤0.01% 589
2024
Q1 		$4K Hold
100
– – ﹤0.01% 580
2023
Q4 		$4K Hold
100
– – ﹤0.01% 631
2023
Q3 		$3K Hold
100
– – ﹤0.01% 741
2023
Q2 		$3K Hold
100
– – ﹤0.01% 744
2023
Q1 		$4K Hold
100
– – ﹤0.01% 678
2022
Q4 		$4K Hold
100
– – ﹤0.01% 683
2022
Q3 		$3K Hold
100
– – ﹤0.01% 706
2022
Q2 		$3K Hold
100
– – ﹤0.01% 712
2022
Q1 		$3K Hold
100
– – ﹤0.01% 697
2021
Q4 		$4K Hold
100
– – ﹤0.01% 680
2021
Q3 		$5K Hold
100
– – ﹤0.01% 644
2021
Q2 		$3K Buy
+100
New +$2.75K ﹤0.01% 694

Other funds holding CLDX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

TS Financial Group (TSFG)'s CLDX Position: Q2 2026 in Review

TS Financial Group (TSFG) held its Celldex Therapeutics (CLDX) position steady in Q2 2026 at 50 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #764.

TS Financial Group (TSFG) first reported a position in CLDX in Q2 2021 and has held it in 21 quarters since. The position peaked at $5K in Q3 2021. 37 funds tracked by Wall St. Rank hold CLDX as of Q2 2026.

  • TS Financial Group (TSFG) held 50 shares of Celldex Therapeutics worth $2K as of Q2 2026.
  • TS Financial Group (TSFG) left its Celldex Therapeutics share count unchanged in Q2 2026.
  • Celldex Therapeutics made up ﹤0.01% of TS Financial Group (TSFG)'s portfolio in Q2 2026, its #764 holding.
  • TS Financial Group (TSFG) first reported a position in Celldex Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • TS Financial Group (TSFG)'s Celldex Therapeutics position peaked at $5K in Q3 2021.
  • 37 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q2 2026.

Based on TS Financial Group (TSFG)'s 13F filing for Q2 2026, filed 23 Jul 2026.